LiverGroup.org. Case Report Form (CRF) for STAGED procedures

Size: px
Start display at page:

Download "LiverGroup.org. Case Report Form (CRF) for STAGED procedures"

Transcription

1 Case Report Form (CRF) for STAGED procedures Patient Characteristics Case number * Age * ( 18)y Gender * Male Female Race * Caucasian Asian African Other If other race, please specify Height * cm Weight * kg Disease Characteristics Comorbidities * ne Coronary Artery Disease. Heart Failure Diabetes Mellitus Metastatic Ca. Hepatitis B or C Cirrhosis Stroke COPD/Asthma Other Reason for liver resection * Benign liver disease. Malignancy Other If other reason, please specify Tumor type * Cholangiocarcinoma hilar Cholangiocarcinoma intrahepatic Colorectal liver metastases Focal nodular hyperplasia. Hemangioma Hepatic adenoma Hepatoblastoma Hepatocellular carcinoma dular regenerative hyperplasia n-colorectal liver metastases Sarcoma Other If non-colorectal liver metastasis, specify If hilar cholangiocarcinoma, indicate Bismuth type I II IIIa IIIb IV Preoperative biliary drainage Endoscopic biliary drainage Endonasal biliary drainage Percutaneous transhepatic biliary drainage If preoperative biliary drainage, indicate side Left Right Both left and right Preoperative cholangitis Disease Characteristics continued If colorectal cancer, indicate mutation(s) ne KRAS BRAF CDX2 Unknown Total number of tumors # Diameter of the largest tumor mm Sequence Synchronous Primary first Liver first Combined Metachronous TNM classification of the primary Tx Tis T1 T2 T3 T4a T4b N0 N1 N2, M0 M1a M1b CEA in serum prior to liver resection ng/ml Chemotherapy prior to Stage 1 * If chemotherapy, which agent? FOLFOX FOLFIRI Other Number of cycles. Biological agent used * If biological, which agent? Cetuximab Bevacizumab Other Previous abdominal surgery prior to Stage 1*. Previous liver resection prior to Stage 1 * Liver parenchyma* Unknown rmal Fibrosis Cirrhosis Steatosis Chemo Dialysis prior to stage 1* Laboratory values prior to stage 1 INR prior to Stage 1 ratio Bilirubin prior to Stage 1 µmol/l The reference range of total bilirubin is typically Creatinine prior to Stage 1 µmol/l ICG plasma disappearance rate % IGC retention at 15 min % To convert lab values from mg/dl to μmol/l use our online converter:

2 Liver volume and function prior to stage 1 Total liver volume (volumetry) cc FLR (voluemtry) cc sflr ratio Use our online sflr calculator to calculate the statdardised FLR: HIDA FLR liver segments (multiple options) HIDA Amsterdam index of FLR prior to Stage 1 %/min/m2 Bilirubin at time of HIDA scan prior to Stage 1 µmol/l The reference range of total bilirubin is typically 2-20 µmol/l. Stage 1 Procedure Characteristics Intended approach for the two stage procedure * Two stage hepatectomy with PVL Two stage hepatectomy with PVE Classic ALPPS Hybrid ALPPS Tourniquet ALPPS Partial ALPPS Mini ALPPS Other Operation duration for Stage 1 min Mode of operation * Open Laparoscopic Robotic Hybrid If hybrid, please explain: Procedure characteristics for stage 1 Procedure performed * Please describe the procedure performed above. Example stage 1 classic ALPPS with right trisectionectomy plane and wedge resection segment 2, T-tube insertion. Exploration without resection * Stage 1 Procedure Segments ne Wedge Resection Ablation If wedge resections for Stage 1, number Procedure characteristics continued If ablation, device used for stage 1 Radiofrequency (RFA) Ethanol Microwave Cryotherapy Nanoknife Other Complexity features for stage 1 (multiple allowed) ne hilar lymphadenectomy more than 1 liver resection resection and ablation portal vein resection and reconstruction hepatic vein resection and reconstruction hepatic artery resection and reconstruction vena cava resection and reconstruction bile duct resection and extrahepatic reconstruction bile duct resection and intrahepatic reconstruction associated enteric resection and reconstruction extrahepatic non-gastrointestinal resection ante situ perfusion and resection ex situ perfusion and resection If vena cava reconstruction, indicate material Autologous Prosthetic Biological Exposure for Stage 1 * (multiple allowed) t applicable (like in wedge or ex situ) Right lobe mobilization Hanging maneuver Anterior approach Laparoscopic Robotic Vascular exclusion for Stage 1 (multiple allowed) ne On-demand Pringle Intermittent Pringle Pringle + vena cava inferior clamping. Total vascular exclusion Total clamp time min Transection for Stage 1 * (multiple allowed) Transection for Stage 1 Crush clamp CUSA Bipolar Stapler ne Other Transection time min Intraoperative and first 24h after Stage 1 postop blood transfusions * units Extubated in the operation room*

3 Portal vein embolisation (PVE) after Stage 1 PVE after stage 1* Days from stage until PVE days Postoperative Laboratory Values after Stage 1 Bilirubin 5 days after stage 1 µmol/l Peak bilirubin after stage 1 µmol/l The reference range of total bilirubin is typically 2-20 INR 5 days after stage 1 ratio Creatinine 48 hours after Stage 1 µmol/l Maximum lactate levels afer stage 1 μmol/l rmal range values for venous lactate are Dialysis/CVVH 5 day after stage 1. In-Hospital Complications after Stage 1 Clavien-Dindo Classification until stage 2. Please indicate the grade and number of complications for each grade below: Grade I number of complications * # Grade II number of complications * # Grade IIIa number of complications * # Grade IIIb number of complications * # Grade IVa number of complications * # Grade IVb number of complications * # Grade V - Death * Alive Dead FABIB Classification after stage 1* Failure Ascites Bile leak Infection ne A B C Bleeding Hospitalisation for stage 1 alone Discharged home between the two Stages? ICU stay for stage 1 * days Hospital stay for stage 1 alone * days Death (90 day) after stage 1 * 90 day follow up not yet completed. Unknown If death, cause of death Readmission (90 day) * 90 day follow up not yet completed Unknown Stage 2 Procedure Stage 2 Procedure Characteristics Was a planned Stage 2 Procedure performed? * Days from Stage 1 to Stage 2 days Operation duration for Stage 2 min Mode of resection for Stage 2 Open Laparoscopic Robotic Hybrid If hybrid for Stage 2, please explain Laboratory Values prior to Stage 2 INR prior to Stage 2 ratio Bilirubin prior to Stage 2 µmol/l The reference range of total bilirubin is typically Creatinine prior to Stage 2 µmol/l ICG plasma disappearance rate % IGC retention at 15 min % To convert lab values from mg/dl to μmol/l use our online converter: Liver volume and function prior to stage 2 Total liver volume (volumetry) cc FLR (voluemtry) cc sflr ratio Days from pre-stage 1 to pre-stage 2 volumetry imaging days HIDA FLR liver segments (multiple options) HIDA Amsterdam index of FLR prior to Stage 2 %/min/m2 Bilirubin at time of HIDA scan prior to Stage 2 µmol/l Procedure characteristics for stage 2 Exploration without resection * Procedure performed * Stage 2 Procedure Segments ne Wedge Resection Ablation

4 Procedure characteristics for stage continued If wedge resections for Stage 2, number If ablation, indicate the device used Radiofrequency (RFA) Ethanol Microwave Cryotherapy Nanoknife Other Complexity features for stage 2 (multiple allowed) ne hilar lymphadenectomy more than 1 liver resection resection and ablation portal vein resection and reconstruction hepatic vein resection and reconstruction hepatic artery resection and reconstruction vena cava resection and reconstruction bile duct resection and extrahepatic reconstruction bile duct resection and intrahepatic reconstruction associated enteric resection and reconstruction extrahepatic non-gastrointestinal resection ante situ perfusion and resection ex situ perfusion and resection (indicate below) If vena cava reconstruction, indicate material Autologous Prosthetic Biological Exposure for stage 2 (multiple allowed) t applicable (like in wedge or ex situ) Right lobe mobilization Hanging maneuver Anterior approach Laparoscopic Robotic Vascular exclusion for stage 2 (multiple allowed) ne On-demand Pringle Intermittent Pringle Pringle + vena cava inferior clamping Total vascular exclusion Total clamp time min Transection for stage 2 (multiple allowed) Transection for stage 2 Clamp crush CUSA Bipolar Stapler ne Other Transection time for stage 2 min Intraoperative and first 24h Stage 2 postop blood transfusions units Extubated in the operation room Postoperative Laboratory Values after Stage 2 Bilirubin 5 days after stage 2 µmol/l Peak bilirubin after stage 2 µmol/l The reference range of total bilirubin is typically 2-20 INR 5 days after stage 2 ratio Creatinine 48 hours after Stage 2 µmol/l Maximum lactate levels after stage 2 μmol/l rmal range values for venous lactate are Dialysis/CVVH 5 after stage 2. Complications after Stage 2 Clavien-Dindo Classification from stage 2 and up to 90 days from stage 1. Please indicate the grade and number of complications for each grade below: Grade I number of complications # Grade II number of complications # Grade IIIa number of complications # Grade IIIb number of complications # Grade IVa number of complications # Grade IVb number of complications # Grade V - Death Alive Dead FABIB Classification after stage 2 Failure Ascites Bile leak Infection ne A B C Bleeding Hospitalisation for stage 2 alone ICU stay for stage 2 days Hospital stay for stage 2 days Death after stage 2 up to 90 days after stage 1 90 day follow up not yet completed. Unknown If dead, cause of death Readmission after stage 2 up to 90 days after stage 1 90 day follow up not yet completed Unknown

5 Completion of data for both stages Please confirm below whether all data until hospital discharge and/or the 90 day follow up from stage 1 up are completed. All data until discharge from hospital are completed * All data until the 90th postoperative day after stage 1 are completed * Instructions Mandatory fields: All field names followed by an asterisk (*) are mandatory for case submission. Case Number: Please add the unique case number as an identifier. Do not use the hospital number or patient identifiers. Please keep a separate list of anonymized case numbers linking to the patient hospital number somewhere safe at your institution. This will help you identify patients in the CRF for further editing if needed. Calculators: The LiverGroup.org platform has integrated calculators for your convenience and to ensure uniform data collection. You may find Laboratory Unit Converters and the sflr Calculator. Terminology: The LiverGroup.org platform has further information regarding the following classifications: Brisbane, Clavien-Dindo, FABIB, BCLC Staging and the Bismuth-Corlette classifications. Comments (optional)

Case Report In Situ Split of the Liver When Portal Venous Embolization Fails to Induce Hypertrophy: A Report of Two Cases

Case Report In Situ Split of the Liver When Portal Venous Embolization Fails to Induce Hypertrophy: A Report of Two Cases Case Reports in Surgery Volume 2013, Article ID 238675, 4 pages http://dx.doi.org/10.1155/2013/238675 Case Report In Situ Split of the Liver When Portal Venous Embolization Fails to Induce Hypertrophy:

More information

Management of Colorectal Liver Metastases

Management of Colorectal Liver Metastases Management of Colorectal Liver Metastases MM Bernon, JEJ Krige HPB Surgical Unit, Groote Schuur Hospital Department of Surgery, University of Cape Town 50% of patients with colorectal cancer develop liver

More information

Liver Tumors. Prof. Dr. Ahmed El - Samongy

Liver Tumors. Prof. Dr. Ahmed El - Samongy Liver Tumors Prof. Dr. Ahmed El - Samongy Objective 1. Identify the most important features of common benign liver tumors 2. Know the risk factors, diagnosis, and management of hepatocellular carcinoma

More information

State of the art management of Colorectal Liver Metastasis: an interplay of Chemotherapy and Surgical options

State of the art management of Colorectal Liver Metastasis: an interplay of Chemotherapy and Surgical options State of the art management of Colorectal Liver Metastasis: an interplay of Chemotherapy and Surgical options Ioannis S. Hatzaras, MD, MPH, FACS Assistant Professor of Surgery Division of Surgical Oncology

More information

NAACCR Webinar Series 1

NAACCR Webinar Series 1 Collecting Cancer Data: Liver 2013 2014 NAACCR Webinar Series June 5, 2014 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching

More information

Liver surgery, acute GI tract bleeding

Liver surgery, acute GI tract bleeding Semmelweis University, Faculty of Medicine, 1 st Department of Surgery Liver surgery, acute GI tract bleeding Oszkár HAHN M.D. LIVER CYST US, CT, MRI Parasite (ELISA, eosinophil, anaphylaxy) Echinococcus

More information

ACS-NSQIP Procedure Targeted Variables: Liver Resection. Thomas A. Aloia, MD, FACS Surgeon Champion

ACS-NSQIP Procedure Targeted Variables: Liver Resection. Thomas A. Aloia, MD, FACS Surgeon Champion ACS-NSQIP Procedure Targeted Variables: Liver Resection Thomas A. Aloia, MD, FACS Surgeon Champion Goals of the Session Examine the History of PTVs in Liver Surgery Discuss proposed PTVs Additions Subtractions

More information

Current Treatment Strategies for Hilar and Intrahepatic Cholangiocarcinoma

Current Treatment Strategies for Hilar and Intrahepatic Cholangiocarcinoma Current Treatment Strategies for Hilar and Intrahepatic Cholangiocarcinoma Jean-Nicolas Vauthey, MD, FACS Professor of Surgery Chief Hepato-Pancreato-Biliary Section Department of Surgical Oncology Crescent

More information

Liver Tumors. Patient Education. Treatment options 8 4A. About the Liver. Surgical Specialties

Liver Tumors. Patient Education. Treatment options 8 4A. About the Liver. Surgical Specialties Patient Education Treatment options This handout describes different kinds of tumors that form in the liver and how they are treated. About the Liver Your liver is the largest organ in your abdomen. It

More information

Treatment of Colorectal Liver Metastases State of the Art

Treatment of Colorectal Liver Metastases State of the Art Treatment of Colorectal Liver Metastases State of the Art Eddie K. Abdalla, MD, FACS Professor and Chairman of Surgery Chief of Hepatobiliary Surgery Hilton Metropolitan Palace Hotel Beirut 16 November,

More information

Liver 6/5/14. Collecting Cancer Data: Liver NAACCR Webinar Series. June 5, 2014

Liver 6/5/14. Collecting Cancer Data: Liver NAACCR Webinar Series. June 5, 2014 Collecting Cancer Data: Liver 2013 2014 NAACCR Webinar Series June 5, 2014 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching

More information

LIVER SURGERY 2. Case 1. Med 5 Refresher Course (Surgery) 2013/14. Dr Sunny Cheung

LIVER SURGERY 2. Case 1. Med 5 Refresher Course (Surgery) 2013/14. Dr Sunny Cheung LIVER SURGERY 2 Med 5 Refresher Course (Surgery) 2013/14 24 Jun 2013 Dr Sunny Cheung Case 1 50/M Sudden onset of epigastric pain Abdominal distension Confused HR 120 BP 80/50 Haemocue = 8 What should you

More information

Long R. Jiao, David N. Hakim, Tamara M. H. Gall, Ana Fajardo, Tim D. Pencavel, Ruifang Fan, Mikael H. Sodergren

Long R. Jiao, David N. Hakim, Tamara M. H. Gall, Ana Fajardo, Tim D. Pencavel, Ruifang Fan, Mikael H. Sodergren How We Do It A totally laparoscopic associating liver partition and portal vein ligation for staged hepatectomy assisted with radiofrequency (radiofrequency assisted liver partition with portal vein ligation)

More information

pitfall Table 1 4 disorientation pitfall pitfall Table 1 Tel:

pitfall Table 1 4 disorientation pitfall pitfall Table 1 Tel: 11 687 692 2002 pitfall 1078 29 17 9 1 2 3 dislocation outflow block 11 1 2 3 9 1 2 3 4 disorientation pitfall 11 687 692 2002 Tel: 075-751-3606 606-8507 54 2001 8 27 2002 10 31 29 4 pitfall 16 1078 Table

More information

Interventional Radiology in Liver Cancer. Nakarin Inmutto MD

Interventional Radiology in Liver Cancer. Nakarin Inmutto MD Interventional Radiology in Liver Cancer Nakarin Inmutto MD Liver cancer Primary liver cancer Hepatocellular carcinoma Cholangiocarcinoma Metastasis Interventional Radiologist Diagnosis Imaging US / CT

More information

LIVER. Question 1 ~ Anatomy. Answer 1 ~ Anatomy 1/5/2018. SEMCME Board Review January 11-12, 2017

LIVER. Question 1 ~ Anatomy. Answer 1 ~ Anatomy 1/5/2018. SEMCME Board Review January 11-12, 2017 SEMCME Board Review January 11-12, 2017 Surgical Treatment of Hepatobiliary and Splenic Disorders Michael J. Jacobs, MD, FACS, FICS Clinical Professor of Surgery- MSU CHM Associate Chair of Surgery Director

More information

Surgical Treatment of Hepatobiliary and Splenic Disorders

Surgical Treatment of Hepatobiliary and Splenic Disorders SEMCME Board Review January 10-11, 2019 Surgical Treatment of Hepatobiliary and Splenic Disorders Michael J. Jacobs, MD, FACS, FICS Clinical Professor of Surgery- MSU CHM Associate Chair of Surgery Director

More information

Multidisciplinary Treatment Strategies for Primary and Metastatic Liver Cancers

Multidisciplinary Treatment Strategies for Primary and Metastatic Liver Cancers Multidisciplinary Treatment Strategies for Primary and Metastatic Liver Cancers Ching-Wei D. Tzeng, M.D. Assistant Professor Surgical Oncology University of Kentucky Markey Cancer Center Affiliate Network

More information

MANAGEMENT OF COLORECTAL METASTASES. Robert Warren, MD. The Postgraduate Course in General Surgery March 22, /22/2011

MANAGEMENT OF COLORECTAL METASTASES. Robert Warren, MD. The Postgraduate Course in General Surgery March 22, /22/2011 MANAGEMENT OF COLORECTAL METASTASES Robert Warren, MD The Postgraduate Course in General Surgery March 22, 2011 Local Systemic LIVER TUMORS:THERAPEUTIC OPTIONS Hepatoma Cholangio. Neuroendo. Colorectal

More information

How to integrate surgery in the treatment of patients with liver-only metastatic disease

How to integrate surgery in the treatment of patients with liver-only metastatic disease How to integrate surgery in the treatment of patients with liver-only metastatic disease Luis Sabater Ortí MD, PhD Associate Professor University of Valencia European Board Surgical Qualification HBP (EBSQ-HPB)

More information

Colorectal Liver Metastases Metachronous

Colorectal Liver Metastases Metachronous Colorectal Liver Metastases Metachronous Professor Rowan Parks Professor of Surgical Sciences University of Edinburgh No disclosures Natural History of Unresected Untreated Colorectal Metastases Year N

More information

6 th August 2018 Day 1 - Gallbladder & Bile duct Topic

6 th August 2018 Day 1 - Gallbladder & Bile duct Topic Venue: Sterling Hospital Auditorium, Sterling Hospitals, Gurukul Road Ahmedabad, Gujarat 6 th August 2018 Day 1 - Gallbladder & Bile duct Registration(8:00am-8:15am) Inauguration(8:15am-8:30am) Welcome

More information

Current Treatment of Colorectal Metastases. Dr. Thavanathan Surgical Grand Rounds February 1, 2005

Current Treatment of Colorectal Metastases. Dr. Thavanathan Surgical Grand Rounds February 1, 2005 Current Treatment of Colorectal Metastases Dr. Thavanathan Surgical Grand Rounds February 1, 2005 25% will have metastases at initial presentation 25-50% 50% will develop metastases later 40% of potentially

More information

Original article: new surgical approaches to the Klatskin tumour

Original article: new surgical approaches to the Klatskin tumour Alimentary Pharmacology & Therapeutics Original article: new surgical approaches to the Klatskin tumour T. M. VAN GULIK*, S. DINANT*, O. R. C. BUSCH*, E. A. J. RAUWS, H. OBERTOP* & D. J. GOUMA Departments

More information

CHIRURGIA EPATOBILIARE IN WEEK SURGERY?

CHIRURGIA EPATOBILIARE IN WEEK SURGERY? U.O.C. di Chirurgia Epatobiliare e dei Trapianti Epatici Università degli Studi di Padova CHIRURGIA EPATOBILIARE IN WEEK SURGERY? Umberto Cillo, MD, PhD, FEBS cillo@unipd.it Quali sono gli ingredienti

More information

Liver surgery for colorectal liver metastases. Keith Roberts, Consultant Liver Transplant and Liver/Pancreas Surgeon University Hospitals Birmingham

Liver surgery for colorectal liver metastases. Keith Roberts, Consultant Liver Transplant and Liver/Pancreas Surgeon University Hospitals Birmingham Liver surgery for colorectal liver metastases Keith Roberts, Consultant Liver Transplant and Liver/Pancreas Surgeon University Hospitals Birmingham Introduction: what do we do? UHB Liver Unit: Liver resections

More information

Techniques to Improve Resectability of Colorectal Liver Metastases Ching-Wei D. Tzeng, M.D.

Techniques to Improve Resectability of Colorectal Liver Metastases Ching-Wei D. Tzeng, M.D. Techniques to Improve Resectability of Colorectal Liver Metastases Ching-Wei D. Tzeng, M.D. Department of Surgery Grand Rounds University of Kentucky January 15, 2014 Metastatic Colorectal Cancer (CRC)

More information

Preoperative Biliary Drainage Among Patients With Resectable Hepatobiliary Malignancy: Does Technique Matter?

Preoperative Biliary Drainage Among Patients With Resectable Hepatobiliary Malignancy: Does Technique Matter? Preoperative Biliary Drainage Among Patients With Resectable Hepatobiliary Malignancy: Does Technique Matter? Q. Lina Hu, MD; Jason B. Liu, MD, MS; Ryan J. Ellis, MD, MS; Jessica Y. Liu, MD, MS; Anthony

More information

Aggressive surgery in the multimodality treatment of liver metastases from colorectal cancer

Aggressive surgery in the multimodality treatment of liver metastases from colorectal cancer Journal of BUON 12: 209-213, 2007 2007 Zerbinis Medical Publications. Printed in Greece ORIGINAL ARTICLE Aggressive surgery in the multimodality treatment of liver metastases from colorectal cancer N.

More information

Management of Cholangiocarcinoma. Roseanna Lee, MD PGY-5 Kings County Hospital

Management of Cholangiocarcinoma. Roseanna Lee, MD PGY-5 Kings County Hospital Management of Cholangiocarcinoma Roseanna Lee, MD PGY-5 Kings County Hospital Case Presentation 37 year old male from Yemen presented with 2 week history of epigastric pain, anorexia, jaundice and puritis.

More information

Liver Cancer And Tumours

Liver Cancer And Tumours Liver Cancer And Tumours What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood from all parts of the body, cancer cells from elsewhere can

More information

Evolution of Surgery: Role of the Surgeon in the Molecular and Technology Age. Yuman Fong, MD Memorial Sloan-Kettering Cancer Center Rio 2010

Evolution of Surgery: Role of the Surgeon in the Molecular and Technology Age. Yuman Fong, MD Memorial Sloan-Kettering Cancer Center Rio 2010 Evolution of Surgery: Role of the Surgeon in the Molecular and Technology Age Yuman Fong, MD Memorial Sloan-Kettering Cancer Center Rio 2010 Molecular mechanisms for cancer Prevention and screening Molecular

More information

Posthepatectomy Liver Failure. C. Jeske

Posthepatectomy Liver Failure. C. Jeske Posthepatectomy Liver Failure C. Jeske Introduction Major source of morbidity and mortality after liver resection Devastating complication Little treatment Incidence: 4-19% Recently < 10% Mortality following

More information

Surgery for hilar cholangiocirconoma

Surgery for hilar cholangiocirconoma Department of Surgery University Hospital RWTH Aachen Surgery for hilar cholangiocirconoma Ulf Peter Neumann Agenda Operating on the most complex tumor in HBP Surgery Preoperative management Does the patient

More information

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital Newcastle HPB MDM updated radiology imaging protocol recommendations Author Dr John Scott. Consultant Radiologist Freeman Hospital This document is intended as a guide to aid radiologists and clinicians

More information

Imaging of liver and pancreas

Imaging of liver and pancreas Imaging of liver and pancreas.. Disease of the liver Focal liver disease Diffusion liver disease Focal liver disease Benign Cyst Abscess Hemangioma FNH Hepatic adenoma HCC Malignant Fibrolamellar carcinoma

More information

Conflicts of Interest

Conflicts of Interest Anesthesia for Major Abdominal Cancer Resection John E. Ellis MD Adjunct Professor University of Pennsylvania johnellis1700@gmail.com Conflicts of Interest 1 Upper Abdominal Surgery Focus on oncologic

More information

Appendix 5. EFSUMB Newsletter. Gastroenterological Ultrasound

Appendix 5. EFSUMB Newsletter. Gastroenterological Ultrasound EFSUMB Newsletter 87 Examinations should encompass the full range of pathological conditions listed below A log book listing the types of examinations undertaken should be kept Training should usually

More information

Liver Transplantation

Liver Transplantation 1 Liver Transplantation Department of Surgery Yonsei University Wonju College of Medicine Kim Myoung Soo M.D. ysms91@wonju.yonsei.ac.kr http://gs.yonsei.ac.kr History Development of Liver transplantation

More information

R.Sotoudehmanesh, MD Professor of Gastroenterology Digestive Disease Research Institute Tehran University of Medical Sciences Pancreatobiliary

R.Sotoudehmanesh, MD Professor of Gastroenterology Digestive Disease Research Institute Tehran University of Medical Sciences Pancreatobiliary R.Sotoudehmanesh, MD Professor of Gastroenterology Digestive Disease Research Institute Tehran University of Medical Sciences Pancreatobiliary /Advanced Endoscopy group Most common biliary malignancy and

More information

HOW I DO IT Feasibility of Bisegmentectomy 7 8 is Independent of the Presence of a Large Inferior Right Hepatic Vein

HOW I DO IT Feasibility of Bisegmentectomy 7 8 is Independent of the Presence of a Large Inferior Right Hepatic Vein Journal of Surgical Oncology 2006;93:338 342 HOW I DO IT Feasibility of Bisegmentectomy 7 8 is Independent of the Presence of a Large Inferior Right Hepatic Vein MARCEL AUTRAN C. MACHADO, MD, 1,2 * PAULO

More information

INTERNATIONAL HEPATO-PANCREATO-BILIARY ASSOCIATION (IHPBA), INDIAN CHAPTER 6TH CERTIFICATE COURSE IN HEPATO-PANCREATO-BILIARY SURGERY

INTERNATIONAL HEPATO-PANCREATO-BILIARY ASSOCIATION (IHPBA), INDIAN CHAPTER 6TH CERTIFICATE COURSE IN HEPATO-PANCREATO-BILIARY SURGERY Day 1-28 th August 2013 Liver TS Ravikumar, Goro Honda, R Surendran, V Sitaram, George Kurien Swatee Halbe, Biju Pottakkat, Vibha Naik, Deepak Barathi 1 Surgical quality and safety Inaugural lecture 2

More information

Liver Ultrasound - Beyond the Basics. Pamela Parker Lead Sonographer

Liver Ultrasound - Beyond the Basics. Pamela Parker Lead Sonographer Liver Ultrasound - Beyond the Basics Pamela Parker Lead Sonographer Aims Review what we know about the liver Reasons for imaging Focal lesions Diffuse disease Can we do more? The Liver The Liver The Liver

More information

Early Outcome of Liver Resections in Octogenarians

Early Outcome of Liver Resections in Octogenarians Early Outcome of Liver Resections in Octogenarians Bhandari RS, 1 Riddiough G, 2 Muralidharan V, 2 Christophi C 2 ABSTRACT Background 1 Tribhuvan University Teaching Hospital. 2 Austin Health, Royal Melbourne

More information

Multiple Primary Quiz

Multiple Primary Quiz Multiple Primary Quiz Case 1 A 72 year old man was found to have a 12 mm solid lesion in the pancreatic tail by computed tomography carried out during a routine follow up study of this patient with adult

More information

Preoperative MELD score as a predictor for post hemihepatectomy complications INAUGURAL-DISSERTATION

Preoperative MELD score as a predictor for post hemihepatectomy complications INAUGURAL-DISSERTATION Aus der Abteilung Allgemein-, Viszeral- und Kinderchirurgie (Prof. Dr. med. M. Ghadimi) im Zentrum Chirurgie der Medizinischen Fakultät der Universität Göttingen Preoperative MELD score as a predictor

More information

Liver resection for HCC

Liver resection for HCC 8 th LIVER INTEREST GROUP Annual Meeting Cape Town 2017 Liver resection for HCC Jose Ramos University of the Witwatersrand Donald Gordon Medical Centre The liver is almost unique in that treatment of the

More information

Liver Cancer (Hepatocellular Carcinoma or HCC) Overview

Liver Cancer (Hepatocellular Carcinoma or HCC) Overview Liver Cancer (Hepatocellular Carcinoma or HCC) Overview Recent advances in liver cancer care seek to address the rising incidence of liver cancer, which has steadily increased over the past three decades.

More information

UvA-DARE (Digital Academic Repository) Enhancement of liver regeneration and liver surgery Olthof, P.B. Link to publication

UvA-DARE (Digital Academic Repository) Enhancement of liver regeneration and liver surgery Olthof, P.B. Link to publication UvA-DARE (Digital Academic Repository) Enhancement of liver regeneration and liver surgery Olthof, P.B. Link to publication Citation for published version (APA): Olthof, P. B. (2017). Enhancement of liver

More information

Functional assessment of the rapidly growing liver

Functional assessment of the rapidly growing liver Functional assessment of the rapidly growing liver Erik Schadde Assistant Professor of Surgery Dept. of Surgery Liver Transplanation and Liver Surgery Rush University Medical Center Chicago Illinois Cantonal

More information

CHOLANGIOCARCINOMA (CCA)

CHOLANGIOCARCINOMA (CCA) CHOLANGIOCARCINOMA (CCA) Deepak Hariharan MD (Research), FRCS, Locum Consultant HPB Surgeon AIM Outline essential facts & principles Present 4 cases Discuss Challenges /Controversies INTRODUCTION Most

More information

Surgical resection for hepatocellular carcinoma (HCC)

Surgical resection for hepatocellular carcinoma (HCC) Surgical resection for hepatocellular carcinoma (HCC) Wojciech G Polak, MD, PhD, FEBS Department of Surgery, Division of HPB and Transplant Surgery, Erasmus MC, University Medical Center Rotterdam the

More information

Endoscopic stenting in bile duct cancer increases liver volume

Endoscopic stenting in bile duct cancer increases liver volume Endoscopic stenting in bile duct cancer increases liver volume Chang Hun Lee 1,3, Seung Young Seo 1,3, Seong Hun Kim 1,3, In Hee Kim 1,3, Sang Wook Kim 1,3, Soo Teik Lee 1,3, Dae Ghon Kim 1,3, Jae Do Yang

More information

University of Colorado Health Sciences Center, Denver Colorado ******************** ******************

University of Colorado Health Sciences Center, Denver Colorado ******************** ****************** University of Colorado Health Sciences Center, Denver Colorado ******************** 1988-2005 ****************** Disclosures No disclosures Case 53 M presents with sudden onset of upper abdominal pain

More information

Case Report Reresection of Colorectal Liver Metastasis with Vena Cava Resection

Case Report Reresection of Colorectal Liver Metastasis with Vena Cava Resection Case Reports in Surgery Volume 2016, Article ID 8173048, 4 pages http://dx.doi.org/10.1155/2016/8173048 Case Report Reresection of Colorectal Liver Metastasis with Vena Cava Resection Ali Tardu, Cuneyt

More information

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center Hepatobiliary Malignancies 206-207 Retrospective Study at Truman Medical Center Brandon Weckbaugh MD, Prarthana Patel & Sheshadri Madhusudhana MD Introduction: Hepatobiliary malignancies are cancers which

More information

Pediatric Liver Tumors and Transplantation. Northwest Regional Pediatric Live Disease Symposium, Seattle WA, April 12, 2008

Pediatric Liver Tumors and Transplantation. Northwest Regional Pediatric Live Disease Symposium, Seattle WA, April 12, 2008 Pediatric Liver Tumors and Transplantation Northwest Regional Pediatric Live Disease Symposium, Seattle WA, April 12, 2008 Liver transplantation for primary liver tumours in children WHEN? - patient selection

More information

Victorian Perioperative Nurses Group Meeting 13/08/2016 LIVER SURGERY. Michael Fink HPB and Liver Transplant Surgeon

Victorian Perioperative Nurses Group Meeting 13/08/2016 LIVER SURGERY. Michael Fink HPB and Liver Transplant Surgeon Victorian Perioperative Nurses Group Meeting 13/08/2016 LIVER SURGERY Michael Fink HPB and Liver Transplant Surgeon Liver surgery Liver resection Liver transplantation Liver resection Indications Maligant

More information

HEPATIC METASTASES. We can state 3 types of metastases depending on their treatment options:

HEPATIC METASTASES. We can state 3 types of metastases depending on their treatment options: HEPATIC METASTASES 1. Definition Metastasis means the spread of cancer. Cancerous cells can separate from the primary tumor and enter the bloodstream or the lymphatic system (the one that produces, stores,

More information

Workup of a Solid Liver Lesion

Workup of a Solid Liver Lesion Workup of a Solid Liver Lesion Joseph B. Cofer MD FACS Chief Quality Officer Erlanger Health System Affiliate Professor of Surgery UTHSC-Chattanooga I have no financial or other relationships with any

More information

Post-operative complications following hepatobiliary surgery: imaging findings and current radiological treatment options

Post-operative complications following hepatobiliary surgery: imaging findings and current radiological treatment options Post-operative complications following hepatobiliary surgery: imaging findings and current radiological treatment options Poster No.: C-1501 Congress: ECR 2015 Type: Educational Exhibit Authors: A. Hadjivassiliou,

More information

Cholangiocarcinoma (Bile Duct Cancer)

Cholangiocarcinoma (Bile Duct Cancer) Cholangiocarcinoma (Bile Duct Cancer) The Bile Duct System (Biliary Tract) A network of bile ducts (tubes) connects the liver and the gallbladder to the small intestine. This network begins in the liver

More information

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 5

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 5 Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 5 Contents 5. Assessment & Management of Liver Metastases 42 5.1. Metachronous

More information

Management of colorectal cancer liver metastases

Management of colorectal cancer liver metastases Management of colorectal cancer liver metastases Aliakbarian M. M.D. Assistant professor of surgery Organ Transplant & Hepatopancreatobiliary Surgeon SUBJECTS The importance of surgical resection in colorectal

More information

Cholangiocarcinoma. GI Practice Guideline. Michael Sanatani, MD, FRCPC (Medical Oncologist) Barbara Fisher, MD, FRCPC (Radiation Oncologist)

Cholangiocarcinoma. GI Practice Guideline. Michael Sanatani, MD, FRCPC (Medical Oncologist) Barbara Fisher, MD, FRCPC (Radiation Oncologist) Cholangiocarcinoma GI Practice Guideline Michael Sanatani, MD, FRCPC (Medical Oncologist) Barbara Fisher, MD, FRCPC (Radiation Oncologist) Approval Date: October 2006 This guideline is a statement of consensus

More information

Intraoperative Ultrasound Guided Liver Resections: A Single Center Experience

Intraoperative Ultrasound Guided Liver Resections: A Single Center Experience ORIGINAL PAPER Surg. Gastroenterol. Oncol. 2018;23(1):31-50 DOI: 10.21614/sgo-23-1-31 Intraoperative Ultrasound Guided Liver Resections: A Single Center Experience Florin Botea 1, Diana Nicolaescu 1, Alexandru

More information

Bile Duct Cancer Early Detection, Diagnosis, and Staging

Bile Duct Cancer Early Detection, Diagnosis, and Staging Bile Duct Cancer Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that can be

More information

Laparoscopic Liver Resection for Hepatocellular Carcinoma

Laparoscopic Liver Resection for Hepatocellular Carcinoma Original Article Laparoscopic Liver Resection for Hepatocellular Carcinoma Carmen D. Chung, Lydia L. Lau, Kwan Lung Ko, Andrew C. Wong, Shezam Wong, Albert C. Chan, Ronnie T. Poon, Chung Mau Lo and Sheung

More information

11/21/13 CEA: 1.7 WNL

11/21/13 CEA: 1.7 WNL Case Scenario 1 A 70 year-old white male presented to his primary care physician with a recent history of rectal bleeding. He was referred for imaging and a colonoscopy and was found to have adenocarcinoma.

More information

Management Algorithms for Primary and Metastatic Liver Cancer

Management Algorithms for Primary and Metastatic Liver Cancer Management Algorithms for Primary and Metastatic Liver Cancer Chief, Division of Surgical Oncology Head Hepatobiliary & Pancreatic Surgery City of Hope Comprehensive Cancer Center Cancer statistics, 2018,

More information

Management of Liver Metastasis from Colorectal Carcinoma. Aisha White, M.D. SUNY Downstate Division of Transplantation

Management of Liver Metastasis from Colorectal Carcinoma. Aisha White, M.D. SUNY Downstate Division of Transplantation Management of Liver Metastasis from Colorectal Carcinoma Aisha White, M.D. SUNY Downstate Division of Transplantation Management of Colorectal Liver Metastasis Epidemiology 25% of patients diagnosed

More information

General summary GENERAL SUMMARY

General summary GENERAL SUMMARY General summary GENERAL SUMMARY In Chapter 2.1 the long-term results and prognostic factors of radiofrequency ablation (RFA) for unresectable colorectal liver metastases (CRLM) in a single center with

More information

Radiofrequency Ablation of Liver Tumors

Radiofrequency Ablation of Liver Tumors Radiofrequency Ablation of Liver Tumors Michael M. Awad, Michael A. Choti Indications and Contraindications Indications Unresectable malignant tumors of the liver (e.g., hepatocellular carcinoma, colorectal

More information

Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer?

Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer? Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer? Lee H, Park JY, Youn S, Kwon W, Heo JS, Choi SH, Choi DW Department of Surgery, Samsung Medical Center Sungkyunkwan

More information

Surgical Management of CBD Injury Jin Seok Heo

Surgical Management of CBD Injury Jin Seok Heo Surgical Management of CBD Injury Jin Seok Heo Department of Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Republic of Korea Bile duct injury (BDI) Introduction Incidence

More information

Interventional radiology

Interventional radiology Interventional radiology Nonvascular Doros Attila MD, Semmelweis Univ. Dept.of Transplantation and Surgery Radiology med IR/MIT Attempted non surgical invasive therapy with good results (sometimes as good

More information

Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: A 20-year experience

Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: A 20-year experience Title Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: A 20-year experience Author(s) Fan, ST; Mau Lo, C; Poon, RTP; Yeung, C; Leung Liu, C; Yuen, WK; Ming Lam, C;

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Abdominal drainage, after hepatic resection, 159 160 Ablation, radiofrequency, for hepatocellular carcinoma, 160 161 Adenocarcinoma, pancreatic.

More information

Hepatocellular Carcinoma: Diagnosis and Management

Hepatocellular Carcinoma: Diagnosis and Management Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm

More information

TRANSEARTERIAL CHEMO- EMBOLIZATION FOR HEPATIC METASTASES FROM NEURO-ENDOCINE NEOPLASIA AND HEPATOMA DR SAMIA AHMAD

TRANSEARTERIAL CHEMO- EMBOLIZATION FOR HEPATIC METASTASES FROM NEURO-ENDOCINE NEOPLASIA AND HEPATOMA DR SAMIA AHMAD UNIVERSITY OF PRETORIA STEVE BIKO ACADEMIC HOSPITAL SOUTH AFRICA TRANSEARTERIAL CHEMO- EMBOLIZATION FOR HEPATIC METASTASES FROM NEURO-ENDOCINE NEOPLASIA AND HEPATOMA DR SAMIA AHMAD 1 INTRODUCTION Hepatic

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Cryosurgical Ablation of Primary or Metastatic Liver Tumors File Name: Origination: Last CAP Review: Next CAP Review: Last Review: cryosurgical_ablation_of_primary_or_metastatic_liver_tumors

More information

Update in abdominal Surgery in cirrhotic patients

Update in abdominal Surgery in cirrhotic patients Update in abdominal Surgery in cirrhotic patients Safi Dokmak HBP department and liver transplantation Beaujon Hospital, Clichy, France Cairo, 5 April 2016 Cirrhosis Prevalence in France (1%)* Patients

More information

Liver Transplantation in Children: Techniques and What the Surgeon Wants to Know from Imaging

Liver Transplantation in Children: Techniques and What the Surgeon Wants to Know from Imaging Liver Transplantation in Children: Techniques and What the Surgeon Wants to Know from Imaging Jaimie D. Nathan, MD Associate Professor of Surgery and Pediatrics Associate Surgical Director, Liver Transplant

More information

Step-by-step isolated resection of segment 1 of the liver using the hanging maneuver

Step-by-step isolated resection of segment 1 of the liver using the hanging maneuver The American Journal of Surgery (2009) 198, e42 e48 HowIDoIt Step-by-step isolated resection of segment 1 of the liver using the hanging maneuver Rafael López-Andújar, Ph.D.*, Eva Montalvá, Ph.D., Marcos

More information

Is it possible to cure patients with liver metastases? Taghizadeh Ali MD Oncologist, MUMS

Is it possible to cure patients with liver metastases? Taghizadeh Ali MD Oncologist, MUMS Is it possible to cure patients with liver metastases? Taghizadeh Ali MD Oncologist, MUMS Survival Rates of by Stage of Adenocarcinoma of the Colon Liver Resection New Perspective Colorectal cancer liver

More information

Intrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1

Intrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1 Intrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1 Jae-Hoon Lim, M.D., Jin Woong Kim, M.D., Suk Hee Heo, M.D., Yong Yeon Jeong, M.D., Heoung Keun Kang, M.D. A 53-year-old

More information

Tumor incidence varies significantly, depending on geographical location.

Tumor incidence varies significantly, depending on geographical location. Hepatocellular carcinoma is the 5 th most common malignancy worldwide with male-to-female ratio 5:1 in Asia 2:1 in the United States Tumor incidence varies significantly, depending on geographical location.

More information

Short-term outcomes after hepatic resection perspective from a developing country

Short-term outcomes after hepatic resection perspective from a developing country 1242 AUDIT ARTICLE Short-term outcomes after hepatic resection perspective from a developing country Saleema Begum, Muhammad Rizwan Khan Abstract Objective: To review the early outcomes of hepatic resection

More information

The safety of the early removal of prophylactic drainage after liver resection based solely on predetermined criteria: a propensity score analysis

The safety of the early removal of prophylactic drainage after liver resection based solely on predetermined criteria: a propensity score analysis http://dx.doi.org/10.1016/j.hpb.2016.12.005 HPB ORIGINAL ARTICLE The safety of the early removal of prophylactic drainage after liver resection based solely on predetermined criteria: a propensity score

More information

Treatment strategy of metastatic rectal cancer

Treatment strategy of metastatic rectal cancer 35.Schweizerische Koloproktologie-Tagung Treatment strategy of metastatic rectal cancer Gilles Mentha University hospital of Geneva Bern, January 18th, 2014 Colorectal cancer is the third most frequent

More information

Radiology of hepatobiliary diseases

Radiology of hepatobiliary diseases GI cycle - Lecture 14 436 Teams Radiology of hepatobiliary diseases Objectives 1. To Interpret plan x-ray radiograph of abdomen with common pathologies. 2. To know the common pathologies presentation.

More information

Hepatobiliary and Pancreatic Malignancies

Hepatobiliary and Pancreatic Malignancies Hepatobiliary and Pancreatic Malignancies Gareth Eeson MD MSc FRCSC Surgical Oncologist and General Surgeon Kelowna General Hospital Interior Health Consultant, Surgical Oncology BC Cancer Agency Centre

More information

Management of Stage IV Colorectal Cancer: Expanding the Horizon

Management of Stage IV Colorectal Cancer: Expanding the Horizon Management of Stage IV Colorectal Cancer: Expanding the Horizon May Tee, MD, MPH and Jan Franko, MD, PhD MercyOne Surgical Group (Mercy Surgical Affiliates) GI Oncology Conference 2019 March 1, 2019 Disclosures

More information

Evaluation of Liver Mass Lesions. American College of Gastroenterology 2013 Regional Postgraduate Course

Evaluation of Liver Mass Lesions. American College of Gastroenterology 2013 Regional Postgraduate Course Evaluation of Liver Mass Lesions American College of Gastroenterology 2013 Regional Postgraduate Course Lewis R. Roberts, MB ChB, PhD Division of Gastroenterology and Hepatology Mayo Clinic College of

More information

CASE STUDIES IN COLORECTAL CANCER: A ROUNDTABLE DISCUSSION

CASE STUDIES IN COLORECTAL CANCER: A ROUNDTABLE DISCUSSION CASE STUDIES IN COLORECTAL CANCER: A ROUNDTABLE DISCUSSION PROVIDED AS AN EDUCATIONAL SERVICE BY THE INSTITUTE FOR CONTINUING HEALTHCARE EDUCATION SUPPORTED BY AN EDUCATIONAL GRANT FROM GENENTECH LEARNING

More information

Treatment of HCC in real life-chinese perspective

Treatment of HCC in real life-chinese perspective Treatment of HCC in real life-chinese perspective George Lau MBBS (HK), MRCP(UK), FHKCP, FHKAM (GI), MD(HK), FRCP (Edin, Lond), FAASLD (US) Chairman Humanity and Health Medical Group, Hong Kong SAR, CHINA

More information

Cystic Disease of the Liver Work Up and Management. Louis Ferrari MD, PGY 3 6/9/16 SUNY Downstate Medical Center

Cystic Disease of the Liver Work Up and Management. Louis Ferrari MD, PGY 3 6/9/16 SUNY Downstate Medical Center Cystic Disease of the Liver Work Up and Management Louis Ferrari MD, PGY 3 6/9/16 SUNY Downstate Medical Center The Case 73F presents to clinic after diagnostic laparoscopy at OSH. Known liver mass for

More information

UPMC Thomas E. Starzl Transplantation Institute Innovative and Novel Indications for Live Donor Liver Transplant (LDLT)

UPMC Thomas E. Starzl Transplantation Institute Innovative and Novel Indications for Live Donor Liver Transplant (LDLT) UPMC PRESBYTERIAN SHADYSIDE TRANSPLANT POLICIES AND PROCEDURES UPMC Thomas E. Starzl Transplantation Institute Innovative and Novel Indications for Live Donor Liver Transplant (LDLT) Alcoholic hepatitis

More information

TREATMENT FOR HCC AND CHOLANGIOCARCINOMA. Shawn Pelletier, MD

TREATMENT FOR HCC AND CHOLANGIOCARCINOMA. Shawn Pelletier, MD TREATMENT FOR HCC AND CHOLANGIOCARCINOMA Shawn Pelletier, MD Treatment for HCC Treatment strategies Curative first line therapy Thermal ablation vs Resection vs Transplant Other first line therapies TACE

More information

Liver imaging takes a step forward with Ingenia

Liver imaging takes a step forward with Ingenia Publication for the Philips MRI Community ISSUE 49 2013 / 2 Liver imaging takes a step forward with Ingenia Lyon South Hospital strives to move from several studies first CT, then MR or PET to using just

More information